Use of MDMA and other illicit drugs by young adult males in northern Spain -: A five-year study

被引:22
作者
Bobes, J
Sáiz, PA
González, MP
Bascarán, MT
Bousoño, M
Ricaurte, GA
McCann, UD
机构
[1] Univ Oviedo, Fac Med, Dept Psychiat, E-33006 Oviedo, Spain
[2] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
关键词
3,4-methylenedioxymethamphetamine epidemiology; military recruits; personality; sensation seeking;
D O I
10.1159/000059385
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim:To measure the prevalence of 3,4-methylenedioxy-methamphetamine (MDMA) and other drug use in young males entering compulsory military service in Asturias (northern Spain) and to define trends in MDMA use in this group during the period from 1995 to 1999. We also sought to determine whether MDMA users have distinct personality features or higher levels of sensation seeking. Methods: 3,634 conscripts [mean age (SD) = 20.19 years (2.52)] who entered military service during the period between 1995 and 1999 were evaluated using the World Health Organization (WHO) questionnaire for drug consumption, the Eysenck Personality Questionnaire-A (EPQ-A), and the Zuckerman Sensation Seeking Scale. Results and Conclusions: The prevalence of lifetime, previous year and previous month MDMA use among military recruits between 1995 and 1999 was 10.9, 7.8 and 4.5%, ranking fifth among illicit drugs ever used. Once individuals used MDMA for the first time, they were likely to use it again, with 71% of individuals who had ever used MDMA reporting that they had used it during the past year (ranking second only to hallucinogens), and 41% reporting having used it in the last month. Compared to recruits who had never used MDMA (but who may have used other illicit drugs), MDMA users had a more extensive drug abuse history. Recruits who had used MDMA during the year prior to study had significantly higher scores on the Neuroticism and Psychoticism Subscales of the EPQ-A, and reported higher levels of sensation seeking. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 45 条
[21]  
KORF DJ, 1995, NEW DRUGS EUROPE OVE
[22]  
KORF DJ, 1996, ANTENNA 1995
[23]  
MCCANN U, 1998, EXTASIS MDMA ABORDAJ, P89
[24]   Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users [J].
McCann, UD ;
Eligulashvili, V ;
Mertl, M ;
Murphy, DL ;
Ricaurte, GA .
PSYCHOPHARMACOLOGY, 1999, 147 (01) :56-65
[25]   Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users:: a controlled study [J].
McCann, UD ;
Mertl, M ;
Eligulashvili, V ;
Ricaurte, GA .
PSYCHOPHARMACOLOGY, 1999, 143 (04) :417-425
[26]   Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings [J].
McCann, UD ;
Szabo, Z ;
Scheffel, U ;
Dannals, RF ;
Ricaurte, GA .
LANCET, 1998, 352 (9138) :1433-1437
[27]  
MCCANN UD, IN PRESS NEUROTOXICI
[28]   Recreational use of "Ecstasy" (MDMA) is associated with elevated impulsivity [J].
Morgan, MJ .
NEUROPSYCHOPHARMACOLOGY, 1998, 19 (04) :252-264
[29]  
PEREZ J, 1986, REV LAT AM PSICOL, V18, P7
[30]  
Peroutka Si, 1990, ECSTASY CLIN PHARM N, P53